Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
PLoS One. 2009 Sep 30;4(9):e7246. doi: 10.1371/journal.pone.0007246.
Clinical association studies have yielded varied results regarding the impact of glucose-6-phosphate dehydrogenase (G6PD) deficiency upon susceptibility to malaria. Analyses have been complicated by varied methods used to diagnose G6PD deficiency.
METHODOLOGY/PRINCIPAL FINDINGS: We compared the association between uncomplicated malaria incidence and G6PD deficiency in a cohort of 601 Ugandan children using two different diagnostic methods, enzyme activity and G6PD genotype (G202A, the predominant East African allele). Although roughly the same percentage of males were identified as deficient using enzyme activity (12%) and genotype (14%), nearly 30% of males who were enzymatically deficient were wild-type at G202A. The number of deficient females was three-fold higher with assessment by genotype (21%) compared to enzyme activity (7%). Heterozygous females accounted for the majority (46/54) of children with a mutant genotype but normal enzyme activity. G6PD deficiency, as determined by G6PD enzyme activity, conferred a 52% (relative risk [RR] 0.48, 95% CI 0.31-0.75) reduced risk of uncomplicated malaria in females. In contrast, when G6PD deficiency was defined based on genotype, the protective association for females was no longer seen (RR = 0.99, 95% CI 0.70-1.39). Notably, restricting the analysis to those females who were both genotypically and enzymatically deficient, the association of deficiency and protection from uncomplicated malaria was again demonstrated in females, but not in males (RR = 0.57, 95% CI 0.37-0.88 for females).
CONCLUSIONS/SIGNIFICANCE: This study underscores the impact that the method of identifying G6PD deficient individuals has upon association studies of G6PD deficiency and uncomplicated malaria. We found that G6PD-deficient females were significantly protected against uncomplicated malaria, but this protection was only seen when G6PD deficiency is described using enzyme activity. These observations may help to explain the discrepancy in some published association studies involving G6PD deficiency and uncomplicated malaria.
临床关联研究对葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症对疟疾易感性的影响得出了不同的结果。由于用于诊断 G6PD 缺乏症的方法各不相同,因此分析变得复杂。
方法/主要发现:我们使用两种不同的诊断方法,酶活性和 G6PD 基因型(G202A,主要的东非等位基因),比较了 601 名乌干达儿童中单纯性疟疾发病率与 G6PD 缺乏症之间的关联。虽然使用酶活性(12%)和基因型(14%)鉴定的男性缺乏症比例大致相同,但近 30%的酶活性缺乏症男性在 G202A 是野生型。通过基因型评估(21%)的女性缺乏症数量是通过酶活性评估(7%)的三倍。杂合子女性占大多数(46/54)具有突变基因型但正常酶活性的儿童。通过 G6PD 酶活性确定的 G6PD 缺乏症使女性患单纯性疟疾的风险降低了 52%(相对风险 [RR] 0.48,95%CI 0.31-0.75)。相比之下,当根据基因型定义 G6PD 缺乏症时,女性的保护关联不再存在(RR = 0.99,95%CI 0.70-1.39)。值得注意的是,将分析限制在那些在基因型和酶活性上均缺乏的女性中,在女性中再次证明了缺乏症与免受单纯性疟疾的关联,但在男性中没有(RR = 0.57,95%CI 0.37-0.88 女性)。
结论/意义:这项研究强调了确定 G6PD 缺乏个体的方法对 G6PD 缺乏症和单纯性疟疾关联研究的影响。我们发现,G6PD 缺乏症女性对单纯性疟疾有明显的保护作用,但只有在使用酶活性描述 G6PD 缺乏症时才能看到这种保护。这些观察结果可能有助于解释一些涉及 G6PD 缺乏症和单纯性疟疾的已发表关联研究中的差异。